相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo
B. S. Hanna et al.
LEUKEMIA (2016)
The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells
D. Saulep-Easton et al.
LEUKEMIA (2016)
Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression
Giovanni Galletti et al.
CELL REPORTS (2016)
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL
Stefano Iacovelli et al.
BLOOD (2015)
Perturbation of the normal immune system in patients with CLL
Francesco Forconi et al.
BLOOD (2015)
hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies
Miguel Gallardo et al.
CANCER CELL (2015)
PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model
T. Motiwala et al.
LEUKEMIA (2015)
Mouse models in the study of chronic lymphocytic leukemia pathogenesis and therapy
Giorgia Simonetti et al.
BLOOD (2014)
How will B-cell-receptor-targeted therapies change future CLL therapy?
Jeffrey A. Jones et al.
BLOOD (2014)
Adaptor Protein GRB2 Promotes Src Tyrosine Kinase Activation and Podosomal Organization by Protein-tyrosine Phosphatase ε in Osteoclasts
Einat Levy-Apter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia
D. Saulep-Easton et al.
LEUKEMIA (2014)
The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling
Layka Abbasi Asbagh et al.
ONCOTARGET (2014)
Estrogen-Sensitive PTPRO Expression Represses Hepatocellular Carcinoma Progression by Control of STAT3
Jiajie Hou et al.
HEPATOLOGY (2013)
Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate
Shu-hao Hsu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function
DJ DiLillo et al.
LEUKEMIA (2013)
B cell receptor signaling in chronic lymphocytic leukemia
Jan A. Burger et al.
TRENDS IN IMMUNOLOGY (2013)
An osteoclastic protein-tyrosine phosphatase regulates the β3-integrin, syk, and shp1 signaling through respective src-dependent phosphorylation in osteoclasts
K. -H. William Lau et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Novel Insights in Molecular Mechanisms of CLL
Nicola Zanesi et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Expression Profiling during Mammary Epithelial Cell Three-Dimensional Morphogenesis Identifies PTPRO as a Novel Regulator of Morphogenesis and ErbB2-Mediated Transformation
Min Yu et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia
Tasneem Motiwala et al.
BLOOD (2011)
A continuum model for tumour suppression
Alice H. Berger et al.
NATURE (2011)
Lyn Kinase and ZAP70 Are Substrates of PTPROt in B-Cells: Lyn Inactivation by PTPROt Sensitizes Leukemia Cells to VEGF-R Inhibitor Pazopanib
Tasneem Motiwala et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Subtle variations in Pten dose determine cancer susceptibility
Andrea Alimonti et al.
NATURE GENETICS (2010)
BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt
Przemyslaw Juszczynski et al.
BLOOD (2009)
Dicer1 functions as a haploinsufficient tumor suppressor
Madhu S. Kumar et al.
GENES & DEVELOPMENT (2009)
CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells
Michelle L. Hermiston et al.
IMMUNOLOGICAL REVIEWS (2009)
被撤回的出版物: PTPROt Inactivates the Oncogenic Fusion Protein BCR/ABL and Suppresses Transformation of K562 Cells (Retracted article. See vol. 293, pg. 3589, 2018)
Tasneem Motiwala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Targeted Transgenic Expression of an Osteoclastic Transmembrane Protein-tyrosine Phosphatase in Cells of Osteoclastic Lineage Increases Bone Resorption and Bone Loss in Male Young Adult Mice
Matilda H. -C. Sheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia
Tasneem Motiwala et al.
CLINICAL CANCER RESEARCH (2007)
Expression of soluble CD27 and interleukins-8 and-10 in B-cell chronic lymphocytic leukemia: Correlation with disease stage and prognosis
Ismail Oguz Kara et al.
ADVANCES IN THERAPY (2007)
Microtubules support production of starvation-induced autophagosomes but not their targeting and fusion with lysosomes
Ephraim Fass et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation
Linfeng Chen et al.
BLOOD (2006)
B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia
Xiao-jie Yan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
An osteoclastic protein-tyrosine phosphatase is a potential positive regulator of the c-Src protein-tyrosine kinase activity: A mediator of osteoclast activity
KHW Lau et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
The TCL1 family of oncoproteins: Co-activators of transformation
MA Teitell
NATURE REVIEWS CANCER (2005)
ZAP-70 expression and prognosis in chronic lymphocytic leukaemia
JA Orchard et al.
LANCET (2004)
An osteoclastic protein-tyrosine phosphatase may play a role in differentiation and activity of human monocytic U-937 cell-derived, osteoclast-like cells
M Amoui et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
被撤回的出版物: Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer (Retracted article. See vol. 119, 2022)
T Motiwala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Expression of a structurally unique osteoclastic protein-tyrosine phosphatase is driven by an alternative intronic, cell type-specific promoter
M Amoui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas
T Motiwala et al.
ONCOGENE (2003)
Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
R Bichi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cell cycle effects of IL-10 on malignant B-1 cells
SY Chong et al.
GENES AND IMMUNITY (2001)
Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome
L Fayad et al.
BLOOD (2001)
Universal PCR amplification of mouse immunoglobulin gene variable regions:: the design of degenerate primers and an assessment of the effect of DNA polymerase 3′ to 5′ exonuclease activity
ZD Wang et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2000)